Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 575Neoplasms 470Lung Neoplasms 303Colorectal Neoplasms 297Carcinoma, Non-Small-Cell Lung 219Stomach Neoplasms 215Carcinoma, Hepatocellular 204Prostatic Neoplasms 183Pancreatic Neoplasms 156Ovarian Neoplasms 143Uterine Cervical Neoplasms 128Colonic Neoplasms 122Rectal Neoplasms 113Urinary Bladder Neoplasms 100Neoplasm Metastasis 95Esophageal Neoplasms 90Endometrial Neoplasms 86Head and Neck Neoplasms 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Leukemia, Myeloid, Acute 79Brain Neoplasms 69Recurrence 68Melanoma 66Disease 65Liver Neoplasms 60Multiple Myeloma 59Lymphoma 59Glioma 58Squamous Cell Carcinoma of Head and Neck 54Polycystic Ovary Syndrome 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Observational × Herpesviridae Infections × Clear all
NCT01248598 2010-11-25

The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis

Rambam Health Care Campus

Unknown
10 enrolled

Herpesviridae Infections, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡